首页> 外文期刊>World Journal of Gastroenterology >Ligustrazine alleviates acute renal injury in a rat model of acute necrotizing pancreatitis.
【24h】

Ligustrazine alleviates acute renal injury in a rat model of acute necrotizing pancreatitis.

机译:川gust嗪减轻急性坏死性胰腺炎大鼠模型的急性肾损伤。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To evaluate the effect of ligustrazine, a traditional Chinese medicine, on renal injury in a rat model of acute necrotizing pancreatitis (ANP). METHODS: A total of 192 rats were randomly divided into three groups: control (C group), ANP without treatment (P group), and ANP treated with ligustrazine (T group). Each group was further divided into 0.5, 2, 6, 12 h subgroups. All rats were anesthetized with an intraperitoneal injection of sodium pentobarbital. Sodium taurocholate was infused through the pancreatic membrane to induce ANP. T group was infused sodium taurocholate as above, and 0.6% ligustrazine was then administered via the femoral vein. Serum urea nitrogen (BUN) and creatinine (Cr) concentrations were measured for the evaluation of renal function. The effects of ligustrazine on the severity of renal injury were assessed by renal function, TXA(2)/PGI(2) and histopathological changes. Renal blood flow was determined by the radioactive microsphere technique (RMT). RESULTS: Compared with control group, the renal blood flow in P group was decreased significantly. Serious renal and pancreatic damages were found in P group, the BUN and Cr levels were elevated significantly, and the ratio of TXA(2) to PGI(2) was increased at 2, 6 and 12 h. Compared with P group, the blood flow of kidney was elevated significantly at 6 and 12 h after induction of ANP, the renal and pancreatic damages were attenuated, and the BUN and Cr levels were decreased significantly, and the ratio of TXA(2) to PGI(2) was decreased at 6 and 12 h in T group. CONCLUSION: Microcirculatory disorder (MCD) is an important factor for renal injury in ANP. Ligustrazine can ameliorate the condition of MCD and the damage of pancreas and kidney.
机译:目的:评价中药川gust嗪对急性坏死性胰腺炎(ANP)大鼠模型肾功能的影响。方法:将192只大鼠随机分为三组:对照组(C组),未经治疗的ANP(P组)和川li嗪治疗的ANP(T组)。每组进一步分为0.5、2、6、12 h亚组。腹膜内注射戊巴比妥钠麻醉所有大鼠。通过胰腺膜注入牛磺胆酸钠以诱导ANP。 T组按上述方法输注牛磺胆酸钠,然后经股静脉给药0.6%川azine嗪。测量血清尿素氮(BUN)和肌酐(Cr)的浓度以评估肾功能。通过肾功能,TXA(2)/ PGI(2)和组织病理学变化评估川gust嗪对肾损伤严重程度的影响。肾血流量通过放射性微球技术(RMT)确定。结果:与对照组相比,P组肾脏血流明显减少。 P组在2、6和12 h肾脏和胰腺严重受损,BUN和Cr水平显着升高,TXA(2)与PGI(2)的比例增加。与P组相比,ANP诱导后6和12 h肾血流量显着升高,肾脏和胰腺损害减轻,BUN和Cr水平明显降低,TXA(2)与T组在6和12 h PGI(2)降低。结论:微循环障碍(MCD)是ANP肾损伤的重要因素。川gust嗪可以改善MCD的状况以及胰腺和肾脏的损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号